TABLE 5.
S48168 concentrations in plasma and GC muscle in the 4 wk treatment groups and in the 12 wk treatment groups
| Matrix | Parameter | Unit | 10 mg/kg |
50 mg/kg |
||
|---|---|---|---|---|---|---|
| Mean | CV% | Mean | CV% | |||
| 4 Wk treatment by UNIBA | ||||||
| Plasma | Concentration | µg/ml | 0.881 | 31 | 3.023 | 34 |
| Skeletal muscle (GC) | Concentration | µg/g | 0.151 | 31 | 0.512 | 48.7 |
| KP | 0.18 | 28.7 | 0.174 | 27.9 | ||
| 12 Wk treatment by AGA | ||||||
| Plasma | Concentration | µg/ml | 6.125 | 44.4 | 18.775 | 25.7 |
| Skeletal muscle (GC) | Concentration | µg/g | 0.552 | 40.6 | 1.716 | 32 |
| KP | 0.093 | 15.3 | 0.094 | 28.6 | ||
| 12 Wk treatment by UNIBA | ||||||
| Plasma | Concentration | µg/ml | 0.893 | 54.6 | 5.889 | 75.2 |
| Skeletal muscle (GC) | Concentration | µg/g | 0.123 | 45.5 | 1.156 | 42 |
| KP | 0.139 | 21.7 | 0.259 | 70.3 | ||
KP, plasma partition coefficient.